Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €6.24B | 38.3x | €7.05 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Grifols | Madrid | Healthcare | Pharmaceuticals | €6.24B | 38.3x | €9.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Laborat.Rovi | Madrid | Healthcare | Pharmaceuticals | €3.15B | 19.9x | €61.40 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.4% Upside | Upgrade to Pro+ | ||
Almirall | Madrid | Healthcare | Pharmaceuticals | €1.73B | -38.5x | €8.08 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.8% Upside | Upgrade to Pro+ | ||
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €1.34B | 2,190x | €76.70 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | ||
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.08B | 11x | €3.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.7% Upside | Upgrade to Pro+ | ||
Natac Natural Ingredients | Madrid | Healthcare | Pharmaceuticals | €295.67M | -39.2x | €0.68 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €201.75M | 21.2x | €2.53 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €20.14M | -11.7x | -0.2 | €3.02 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.1% Downside | Upgrade to Pro+ |